240 Participants Needed

Resistance Exercise for Cardiovascular Risk

(DoReps Trial)

DL
Overseen ByDuck-chul Lee, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine how varying amounts of resistance exercise, such as weight lifting, can help prevent heart disease. It will compare three groups engaging in different exercise amounts to identify the most effective regimen. The goal is to provide better guidance on the necessary amount of resistance exercise for maintaining heart health. Individuals who are overweight or obese, do not smoke, and have not been exercising regularly may be suitable candidates for this trial. Participants must be able to perform the exercise routines planned for the study. As an unphased trial, this study offers participants the chance to contribute to significant research that could enhance heart health recommendations for everyone.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to consult with the trial coordinators or your doctor for guidance.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that resistance exercise, such as weight lifting, is generally safe and beneficial for heart health. Studies have found that it can lower the risk of heart disease, reduce blood pressure, and aid in weight management. Adults, whether or not they have heart disease, usually tolerate resistance exercise well.

The available data report no major safety concerns, indicating that resistance exercise is safe for most people when performed correctly. To avoid injury, start slowly and gradually increase intensity. Those with specific health conditions should consult a doctor before beginning any new exercise routine.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how different types of exercise can impact cardiovascular risk, a key factor in heart health. Unlike traditional treatments that rely on medication to manage cardiovascular risk, this study looks at varying amounts of resistance exercise combined with aerobic workouts to see how they can improve heart health. The trial compares different doses of resistance exercise, from 30 to 120 minutes per week, coupled with aerobic activities, and contrasts them with aerobic exercise alone. This approach is unique because it examines the potential benefits of integrating resistance exercises, which are often overlooked, into heart health strategies. Researchers hope to find out whether resistance training can provide an effective, non-medication-based option for reducing cardiovascular risk.

What evidence suggests that this trial's treatments could be effective for cardiovascular disease prevention?

Research has shown that strength training can significantly reduce the risk of heart disease. Studies have found that adults who engage in strength exercises have about a 17% lower chance of developing heart problems compared to those who do not. This trial will compare different durations of resistance exercise, with some participants engaging in 30, 60, or 120 minutes of resistance exercise per week, each combined with aerobic exercise. Another group will perform only aerobic exercise. Combining strength and aerobic exercises appears to enhance heart health further. Other research suggests that activities like strength training can lower the risk of dying from any cause by up to 17%. While aerobic exercise is already known to benefit heart health, adding strength exercises could amplify these benefits.34678

Who Is on the Research Team?

DL

Duck-chul Lee, PhD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for individuals at risk of cardiovascular disease who are interested in understanding how different amounts of resistance exercise can impact their heart health. There's no specific duration mentioned, but participants should be willing to engage in either aerobic or resistance exercises as per the study requirements.

Inclusion Criteria

Inactive: not meeting the US resistance and aerobic exercise guidelines over the last 6 months
Non-Smoker
Overweight or Obese: Body Mass Index 25-43 kg/m2

Exclusion Criteria

I have a serious health condition that could worsen with exercise.
My heart condition is stable.
Pregnancy/anticipated pregnancy during the study
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to varying dosages of resistance exercise for 1 year, with baseline, 6-month, and 12-month physical examinations

12 months
Baseline, 6-month, and 12-month visits

Supervised Exercise

First 6 months of intervention in a supervised lab-based setting, assessing changes in CVD risk factors

6 months

Unsupervised Exercise

Second 6 months in a free-living environment with a health club membership, focusing on adherence

6 months

Follow-up

Participants are monitored for long-term effects and adherence to exercise regimen

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Resistance Exercise
Trial Overview The study is testing four different exercise regimens: 30 minutes, 60 minutes, and 120 minutes of resistance training, compared with aerobic exercise only. The goal is to determine how each amount affects cardiovascular health and establish guidelines for effective exercise doses.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Group I: Aerobic Exercise (AE) onlyExperimental Treatment1 Intervention
Group II: 60 min of resistance exercise (RE)Experimental Treatment1 Intervention
Group III: 30 min of resistance exercise (RE)Experimental Treatment1 Intervention
Group IV: 120 min of resistance exercise (RE)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Harvard School of Public Health (HSPH)

Collaborator

Trials
283
Recruited
17,030,000+

Iowa State University

Collaborator

Trials
63
Recruited
145,000+

University of California, Riverside

Collaborator

Trials
33
Recruited
14,400+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

Regular weight-training can lead to positive adaptations in cardiovascular health, including decreased heart rate during maximal work and improved myocardial structure, which may help reduce the risk of cardiovascular disease.
Resistance training can also enhance aerobic capacity and improve metabolic health markers like glucose tolerance and insulin sensitivity, although caution is advised for individuals with existing cardiovascular conditions due to potential blood pressure responses.
Health- and performance-related potential of resistance training.Stone, MH., Fleck, SJ., Triplett, NT., et al.[2022]
Resistance exercises are safe and effective for patients with coronary artery disease (CAD), post-myocardial infarction (MI), and those who have undergone coronary artery bypass grafting (CABG), as shown in a review of 11 studies from 1997 to 2007.
The benefits of resistance training include improved muscular strength, increased physical capacity, and enhanced emotional well-being and quality of life, with no reported risks associated with the exercises.
Resistance exercises for health promotion in coronary patients: evidence of benefits and risks.Oliveira, JL., Galvão, CM., Rocha, SM.[2011]
Resistance training has been shown to significantly improve survival rates in patients with coronary heart disease, highlighting its importance in secondary prevention of cardiovascular disease.
The review outlines safe practices and specific guidelines for prescribing resistance exercise to cardiac patients, ensuring that the benefits can be maximized while minimizing risks.
Resistance exercise in cardiac rehabilitation.Wise, FM., Patrick, JM.[2011]

Citations

Resistance Training in Cardiovascular Diseases: A Review on ...This review aims to describe the effects of RT on CVD risk factors based on studies retrieved from PubMed and Google Scholar databases.
Resistance Exercise Training in Individuals With and ...Adults who participate in RT have ≈15% lower risk of all-cause mortality and 17% lower risk of CVD, compared with adults who report no RT.
The effect of different resistance exercise training intensities ...A 0.01 increase in WHR has been associated with a 5% increase in risk of cardiovascular disease. Resistance training has been recommended as an effective ...
Comparative effectiveness of aerobic, resistance, and ...Cumulatively our data suggest that concurrent aerobic and resistance training may be a more potent means to improve CVD risk factor burden among ...
a systematic review and meta-analysis of cohort studiesMuscle-strengthening activities were associated with a 10–17% lower risk of all-cause mortality, cardiovascular disease (CVD), total cancer, diabetes and lung ...
AHA Update on Resistance Exercise Training: Key PointsAccumulating evidence suggests resistance training is a safe and effective approach for improving cardiovascular (CV) health in adults with and ...
Efficacy and Safety of Resistance Training for Coronary ...At present, studies have found that RT reduces cardiovascular mortality, prevents obesity, reduces blood pressure, and improves insulin ...
Aerobic, resistance, or combined exercise training and ...Aerobic exercise alone or combined aerobic plus resistance exercise, but not resistance exercise alone, improved CVD risk profile (composite Z- ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security